CDHA CAAR

August 19, 2019

CAAR – US Department of Health and Human Services, Office of Inspector General Report – August 19, 2019

Filed under: Reports and Articles — Tags: , — admin @ 5:45 pm

Medicare Part B Drug Payments: Impact of Price Substitutions Based on 2017 Average Sales Prices,” (OEI-03-19-00260, August 2019, .pdf format, 12p.).

oig.hhs.gov/oei/reports/oei-03-19-00260.asp

August 15, 2019

CAAR – US National Center for Health Statistics Data Brief – August 15, 2019

Filed under: Reports and Articles — Tags: — admin @ 5:34 pm

Prescription Drug Use Among Adults Aged 40–79 in the United States and Canada,” by Craig M. Hales, Jennifer Servais, Crescent B. Martin, and Dafna Kohen (Data Brief No. 347, August 2019, HTML and .pdf format, 8p.).

www.cdc.gov/nchs/products/databriefs/db347.htm

August 2, 2019

CAAR – Kaiser Family Foundation Issue Brief – August 2, 2019

Filed under: Reports and Articles — Tags: , — admin @ 5:00 pm

A Look at Recent Proposals to Control Drug Spending by Medicare and its Beneficiaries,” by Meredith Freed, Juliette Cubanski, and Tricia Neuman (August 2019, HTML and .pdf format, 27p.).

www.kff.org/medicare/issue-brief/a-look-at-recent-proposals-to-control-drug-spending-by-medicare-and-its-beneficiaries/

June 27, 2019

CAAR – AARP Public Policy Institute Report – June 27, 2019

Filed under: Reports and Articles — Tags: — admin @ 4:01 pm

Rx Price Watch Report: Trends in Retail Prices of Specialty Prescription Drugs Widely Used by Older Americans, 2017 Year-End Update,” by Leigh Purvis and Dr. Stephen Schondelmeyer (June 2019, .pdf format, 25p.).

www.aarp.org/ppi/info-2019/trends-in-retail-prices-of-drugs.html?INTCMP=RDRCT-PPI-HEALTH-040919

June 25, 2019

CAAR – Kaiser Family Foundation Issue Brief – June 25, 2019

Filed under: Reports and Articles — Tags: , — admin @ 4:55 pm

How Many Medicare Part D Enrollees Had High Out-of-Pocket Drug Costs in 2017?” by Juliette Cubanski, Tricia Neuman, and Anthony Damico (June 2019, .pdf format, 12p.).

www.kff.org/medicare/issue-brief/how-many-medicare-part-d-enrollees-had-high-out-of-pocket-drug-costs-in-2017/

June 19, 2019

CAAR – US Senate Special Committee on Aging Committee Hearing – June 19, 2019

Filed under: Legislation Information Updates — Tags: — admin @ 4:48 pm

The Complex Web of Prescription Drug Prices, Part III: Examining Agency Efforts to Further Competition and Increase Affordability,” a hearing held June 19, 2019 (witness statements available in .pdf format, video of the full hearing available at the site, running time 1 hour 41 minutes). Note: The hearing begins at the 13:43 mark.

www.aging.senate.gov/hearings/the-complex-web-of-prescription-drug-prices-part-iii-examining-agency-efforts-to-further-competition-and-increase-affordability

 

May 30, 2019

CAAR – Center for Retirement Research at Boston College Working Paper – May 30, 2019

Filed under: Reports and Articles — Tags: , — admin @ 4:50 pm

The Effect of Medicare Part D on Evergreening, Generic Entry, and Drug Prices,” by Geoffrey T. Sanzenbacher and Gal Wettstein (WP No.2019-8, May 2019, .pdf and Excel format, 24p.). Note: Links to the abstract and the full text of this paper available at:

crr.bc.edu/working-papers/the-effect-of-medicare-part-d-on-evergreening-generic-entry-and-drug-prices/

May 29, 2019

CAAR – Journal of the American Medical Association Article Abstract – May 29, 2019

Filed under: Reports and Articles — Tags: , , — admin @ 5:34 pm

Specialty Drug Pricing and Out-of-Pocket Spending on Orally Administered Anticancer Drugs in Medicare Part D, 2010 to 2019,” by Stacie B. Dusetzina, Haiden A. Huskamp, and Nancy L. Keating (Vol. 321, No. 20, May 28, 2019, p. 2025-2027).

jamanetwork.com/journals/jama/article-abstract/2734308

May 23, 2019

CAAR – US National Center for Health Statistics Brief, Report – May 23, 2019

Filed under: Reports and Articles — Tags: , , , , — admin @ 5:47 pm

A. “Strategies Used by Adults Aged 65 and Over to Reduce Their Prescription Drug Costs, 2016–2017,” by Robin A. Cohen and Peter Boersma (NCHS Data Brief No. 335, May 2019, .pdf and HTML format, 7p.).

www.cdc.gov/nchs/products/databriefs/db335.htm

B. “Trends in Cancer and Heart Disease Death Rates Among Adults Aged 45–64: United States, 1999–2017,” by Sally C. Curtin (National Vital Statistics Report, Vol. 68, No. 5, May 2019, .pdf format, 8p.).

www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_05-508.pdf

May 1, 2019

CAAR – US House Committee on Energy and Commerce, Subcommittee on Health Hearing Testimony – May 1, 2019

Filed under: Legislation Information Updates — Tags: , — admin @ 5:38 pm

Prescription Drug Coverage in the Medicare Program,” a hearing held April 30, 2019 (witness statements available in .pdf format, video of the full hearing available at the site, running time 2 hours 9 minutes). Note: Hearing starts at the 11:10 mark, and ends at the 2:23:50 mark.

energycommerce.house.gov/committee-activity/hearings/hearing-on-prescription-drug-coverage-in-the-medicare-program

April 8, 2019

CAAR – AARP Public Policy Institute Report – April 8, 2019

Filed under: Reports and Articles — Tags: — admin @ 4:53 pm

Rx Price Watch Report: Trends in Retail Prices of Generic Prescription Drugs Widely Used by Older Americans: 2017 Year-End Update,” by Leigh Purvis, and Dr. Stephen Schondelmeyer (April 2019, .pdf format, 23p.).

www.aarp.org/ppi/info-2016/trends-in-retail-prices-of-drugs.html

March 21, 2019

CAAR – AARP Public Policy Institute Report – March 21, 2019

Filed under: Reports and Articles — Tags: , — admin @ 5:51 pm

Specialty Drugs in Breast Cancer: Health Care Utilization and Costs in the First Year after Diagnosis,” by Elizabeth Carter and Leigh Purvis (March 2019, .pdf format, 4p.).

www.aarp.org/ppi/info-2019/specialty-drugs-in-breast-cancer-health-care-utilization.html

March 20, 2019

CAAR – Congressional Budget Office Working Paper – March 20, 2019

Filed under: Working Papers — Tags: , , — admin @ 5:18 pm

Prices for and Spending on Specialty Drugs in Medicare Part D and Medicaid: An In-Depth Analysis,” by Anna Anderson-Cook, Jared Maeda, and Lyle Nelson (Working Paper 2019-02, March 2019, .pdf format, 58p.). Note: Links to the abstract and the full text of the paper available at:

www.cbo.gov/publication/55011

March 7, 2019

CAAR – US House Committee on Ways and Means, Subcommittee on Health Hearing Testimony – March 7, 2019

Filed under: Legislation Information Updates — Tags: , — admin @ 4:56 pm

Promoting Competition to Lower Medicare Drug Prices,” a hearing held March 7, 2019 (witness statements available in .pdf format).

waysandmeans.house.gov/legislation/hearings/promoting-competition-lower-medicare-drug-prices

Video of the full hearing available at (running time 2 hours 19 minutes):

www.youtube.com/c/waysandmeanscommitteehearings

CAAR – US Senate Special Committee on Aging Hearing Testimony – March 7, 2019

Filed under: Legislation Information Updates — Tags: — admin @ 4:52 pm

A. “The Complex Web of Prescription Drug Prices, Part I: Patients Struggling with Rising Costs,” a hearing held March 6, 2019 (witness statements available in .pdf format, video of the full hearing available on the site, running time 1 hour 56 minutes). Note: The hearing begins at the 16:04 mark.

www.aging.senate.gov/hearings/the-complex-web-of-prescription-drug-prices-part-i-patients-struggling-with-rising-costs

B. “The Complex Web of Prescription Drug Prices, Part II: Untangling the Web and Paths Forward,” a hearing held March 7, 2019 (witness statements available in .pdf format, video of the full hearing available on the site, running time 1 hour 32 minutes). Note: The hearing begins at the 17:19 mark.

www.aging.senate.gov/hearings/the-complex-web-of-prescription-drug-prices-part-ii-untangling-the-web-and-paths-forward

February 1, 2019

CAAR – National Bureau of Economic Research Working Papers – February 1, 2019

Links to an abstract are available. For full text availability check your organization’s library.

A. “How Many Life-Years Have New Drugs Saved? A 3-Way Fixed-Effects Analysis of 66 Diseases in 27 Countries, 2000-2013,” by Frank R. Lichtenberg (w25483, January 2019, .pdf format, 23p.).

www.nber.org/papers/w25483

B. “The Impact of a Wartime Health Shock on the Postwar Socioeconomic Status and Mortality of Union Army Veterans and their Children,” by Dora Costa, Noelle Yetter, and Heather DeSomer (w25480, January 2019, .pdf format, 47p.).

www.nber.org/papers/w25480

C. “Is There a Demand for Reverse Mortgages in China? Evidence from Two Online Surveys,” by Katja Hanewald, Hazel Bateman, Hanming Fang, and Shang Wu (w25491, January 2019, .pdf format, 35p.).

www.nber.org/papers/w25491

CAAR – Kaiser Family Foundation Issue Brief – February 1, 2019

Filed under: Reports and Articles — Tags: , — admin @ 5:10 pm

The Out-of-Pocket Cost Burden for Specialty Drugs in Medicare Part D in 2019,” by Juliette Cubanski, Wyatt Koma, and Tricia Neuman (January 2019, .pdf and HTML format, 16p.).

www.kff.org/medicare/issue-brief/the-out-of-pocket-cost-burden-for-specialty-drugs-in-medicare-part-d-in-2019/

January 2, 2019

CAAR – Commonwealth Fund Blog – January 2, 2019

Filed under: Reports and Articles — Tags: , — admin @ 5:20 pm

Proposed Changes to Medicare Part D Would Benefit Drug Manufacturers More Than Beneficiaries,” by Shawn Bishop (January 2019).

www.commonwealthfund.org/blog/2019/proposed-changes-medicare-part-d-would-benefit-drug-manufacturers-more-beneficiaries

November 13, 2018

CAAR – Journal of the American Medical Association Article Abstract – November 13, 2018

Filed under: Reports and Articles — Tags: , — admin @ 4:41 pm

Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial,” by Philippe Martin, Robyn Tamblyn, Andrea Benedetti, Sara Ahmed, and Cara Tannenbaum (Vol. 320, No. 18, November 13, 2018, p. 1889-1898).

jamanetwork.com/journals/jama/article-abstract/2714531

 

September 27, 2018

CAAR – AARP Public Policy Institute Report – September 27, 2018

Filed under: Reports and Articles — Tags: — admin @ 5:21 pm

Rx Price Watch Report: Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans: 2017 Year-End Update,” by Leigh Purvis and Dr. Stephen Schondelmeyer (September 2018, .pdf format, 24p.).

www.aarp.org/ppi/info-2016/trends-in-retail-prices-of-drugs.html

August 22, 2018

CAAR – AARP Public Policy Institute Report – August 22, 2018

Filed under: Reports and Articles — Tags: , — admin @ 5:01 pm

Reducing Potential Overuse of Dementia Drugs Could Lead to Considerable Savings,” by Elizabeth A. Carter and Leigh Purvis (August 2018, .pdf format, 6p.).

www.aarp.org/ppi/info-2018/reducing-potential-overuse-of-dementia-drugs-could-lead-to-consi.html

August 21, 2018

CAAR – Journal of the American Medical Association Article Abstracts – August 21, 2018

A. “Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents,” by Chana A. Sacks, ChangWon C. Lee, Aaron S. Kesselheim, and Jerry Avorn (Vol. 320, No. 7, August 21, 2018, p. 650-656).

jamanetwork.com/journals/jama/article-abstract/2697695

B. “Association of Cardiovascular Health Level in Older Age With Cognitive Decline and Incident Dementia,” by Cécilia Samieri, Marie-Cécile Perier, Bamba Gaye, Cécile Proust-Lima, Catherine Helmer, Jean-François Dartigues, Claudine Berr, Christophe Tzourio, and Jean-Philippe Empana (Vol. 320, No. 7, August 21, 2018, p. 657-664).

jamanetwork.com/journals/jama/article-abstract/2697696

August 9, 2018

CAAR – US Department of Health and Human Services, Office of the Inspector General Report – August 9, 2018

Filed under: Reports and Articles — Tags: , — admin @ 5:28 pm

Medicare Part B Drug Payments: Impact of Price Substitutions Based on 2016 Average Sales Prices,” (OEI-03-18-00120, August 2018, .pdf format, 12p.).

oig.hhs.gov/oei/reports/oei-03-18-00120.asp

June 26, 2018

CAAR – US Senate Committee on Finance Hearing Testimony – June 26, 2018

Filed under: Legislation Information Updates — Tags: — admin @ 5:13 pm

Prescription Drug Affordability and Innovation: Addressing Challenges in Today’s Market,” a hearing held June 26, 2018 (witness statement available in .pdf format, video of the full hearing available at the site, running time 2 hours 13 minutes). Note: The hearing begins at the 20:25 mark.

www.finance.senate.gov/hearings/prescription-drug-affordability-and-innovation-addressing-challenges-in-todays-market

June 8, 2018

CAAR – US Department of Health and Human Services, Office of Inspector General Report – June 8, 2018

Filed under: Reports and Articles — Tags: — admin @ 5:11 pm

The Food and Drug Administration Computed Prescription Drug User Fee Rates Accurately,” (A-05-17-00040, June 2018, .pdf format, 4p.).

oig.hhs.gov/oas/reports/region5/51700040.asp

June 4, 2018

CAAR – US Department of Health and Human Services, Office of Inspector General Brief – June 4, 2018

Filed under: Reports and Articles — Tags: , — admin @ 4:25 pm

Increases in Reimbursement for Brand-Name Drugs in Part D,” (OEI 03 15 00080, June 2018, .pdf format, 15p.).

oig.hhs.gov/oei/reports/oei-03-15-00080.asp

 

April 26, 2018

CAAR – National Bureau of Economic Research Working Paper – April 26, 2018

Filed under: Working Papers — Tags: , — admin @ 12:47 pm

Links to an abstract are available. For full text availability check your organization’s library. “The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries,” by Frank R. Lichtenberg (w24536, April 2018, .pdf format, 46p.).

www.nber.org/papers/w24536

April 25, 2018

CAAR – Public Library of Science (PLoS) Article – April 25, 2018

Filed under: Reports and Articles — Tags: , — admin @ 12:23 pm

Medication burden attributable to chronic co-morbid conditions in the very old and vulnerable,” by Kelly L. Moore, Kanan Patel, W. John Boscardin, Michael A. Steinman, Christine Ritchie, and Janice B. Schwartz (PLoS ONE 13(4): e0196109. doi.org/10.1371/journal.pone.0196109, XML, HTML, and .pdf format, 14p.).

journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0196109

March 29, 2018

CAAR – US Senate Committee on Homeland Security and Government Affairs Minority Report – March 29, 2018

Filed under: Reports and Articles — Tags: — admin @ 4:29 pm

Manufactured Crisis: How Devastating Drug Price Increases Are Harming America’s Seniors,” (March 2018, .pdf format, 11p.).

www.hsgac.senate.gov/download/03/27/2018/manufactured-crisis-how-devastating-drug-price-increases-are-harming-americas-seniors

February 8, 2018

CAAR – Center for Retirement Research at Boston College Issue Brief – February 8, 2018

Filed under: Reports and Articles — Tags: — admin @ 4:47 pm

How Do Prescription Drugs Affect the Use of Other Health Services?” by Gal Wettstein (IB No. 18-3, February 2018, .pdf format, 8p.).

How Do Prescription Drugs Affect the Use of Other Health Services?

January 29, 2018

CAAR – National Bureau of Economic Research Working Papers – January 29, 2018

Links to an abstract are available. For full text availability check your organization’s library.

A. “Targeting with In-kind Transfers: Evidence from Medicaid Home Care,” by Ethan M.J. Lieber and Lee M. Lockwood (w24267, January 2018, .pdf format, 74p.).

www.nber.org/papers/w24267

B. “Household Time Use Among Older Couples: Evidence and Implications for Labor Supply Parameters,” by Richard Rogerson and Johanna Wallenius (w24263, January 2018, .pdf format, 55p.).

www.nber.org/papers/w24263

C. “High-Priced Drugs in Medicare Part D: Diagnosis and Potential Prescription,” by Richard G. Frank and Richard J. Zeckhauser (w24240, January 2018, .pdf format, 41p.).

www.nber.org/papers/w24240

 

December 15, 2017

CAAR – AARP Public Policy Institute Report – December 15, 2017

Filed under: Reports and Articles — Tags: — admin @ 4:44 pm

Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: 2006 to 2015,” by Stephen W. Schondelmeyer and Leigh Purvis (December 2017, .pdf format, 16p.).

www.aarp.org/ppi/info-2016/trends-in-retail-prices-of-drugs.html

November 7, 2017

CAAR – Kaiser Family Foundation Issue Brief – November 7, 2017

Filed under: Reports and Articles — Tags: , — admin @ 5:13 pm

No Limit: Medicare Part D Enrollees Exposed to High Out-of-Pocket Drug Costs Without a Hard Cap on Spending,” by Juliette Cubanski, Tricia Neuman, Kendal Orgera, and Anthony Damico (November 2017, .pdf and HTML format, 13p.).

www.kff.org/medicare/issue-brief/no-limit-medicare-part-d-enrollees-exposed-to-high-out-of-pocket-drug-costs-without-a-hard-cap-on-spending/

October 26, 2017

CAAR – Public Library of Science (PLoS) Articles – October 26, 2017

A. “Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia,” by Susan F. Wood, Joanna Podrasky, Meghan A. McMonagle, Janani Raveendran, Tyler Bysshe, Alycia Hogenmiller, and Adriane Fugh-Berman (PLoS ONE12(10): e0186060. doi.org/10.1371/journal.pone.0186060, HTML, XML, and .pdf format, 13p.).

journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0186060

B. “Physical activity and cohabitation status moderate the link between diabetes mellitus and cognitive performance in a community-dwelling elderly population in Germany,” by Anne Fink, Nikolaus Buchmann, Christina Tegeler, Elisabeth Steinhagen-Thiessen, Ilja Demuth, and Gabriele Doblhammer (PLoS ONE12(10): e0187119. doi.org/10.1371/journal.pone.0187119, XML, HTML, and .pdf format, 15p.).

journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0187119

October 20, 2017

CAAR – Kaiser Family Foundation Issue Briefs – October 20, 2017

Filed under: Reports and Articles — Tags: , — admin @ 4:30 pm

A. “Medicare Part D: A First Look at Prescription Drug Plans in 2018,” by Juliette Cubanski, Anthony Damico, Jack Hoadley, Kendal Orgera, and Tricia Neuman (October 2017, .pdf and HTML format, 21p.).

www.kff.org/medicare/issue-brief/medicare-part-d-a-first-look-at-prescription-drug-plans-in-2018/

B. “Medicare Advantage 2018 Data Spotlight: First Look,” by Gretchen Jacobson, Anthony Damico, and Tricia Neuman (October 2017, .pdf and HTML format, 5p.).

www.kff.org/medicare/issue-brief/medicare-advantage-2018-data-spotlight-first-look/

October 2, 2017

CAAR – US Department of Health and Human Services, Office of Inspector General Reports – October 2, 2017

Filed under: Reports and Articles — Tags: , , — admin @ 4:57 pm

A. “Shortcomings of Device Claims Data Complicate and Potentially Increase Medicare Costs for Recalled and Prematurely Failed Devices,” (A-01-15-00504, September 2017, .pdf format, 28p.).

oig.hhs.gov/oas/reports/region1/11500504.asp

B. “Medicare Part B Drug Payments: Impact of Price Substitutions Based on 2015 Average Sales Prices,” (OEI-03-17-00360, September 2017, .pdf format, 10p.).

oig.hhs.gov/oei/reports/oei-03-17-00360.asp

September 12, 2017

CAAR – AARP Public Policy Institute Reports – September 12, 2017

Filed under: Reports and Articles — Tags: , , — admin @ 4:57 pm

A. “From Research to Standard Practice: Advancing Proven Programs to Support Family Caregivers of Persons Living with Dementia,” by Lynn Friss Feinberg (September 2017, .pdf format, 19p.).

www.aarp.org/ppi/info-2017/from-research-to-standard-practice.html

B. “Rx Price Watch Report: Trends in Retail Prices of Specialty Prescription Drugs Widely Used by Older Americans: 2006 to 2015,” by Leigh Purvis and Dr. Stephen Schondelmeyer (September 2017, .pdf format, 30p.).

www.aarp.org/ppi/info-2016/trends-in-retail-prices-of-drugs.html

August 3, 2017

CAAR – AARP Public Policy Institute Report – August 3, 2017

Filed under: Reports and Articles — Tags: — admin @ 3:45 pm

Prescription Drug Abuse among Older Adults,” by Olivia Dean (August 2017, .pdf format, 8p.).

www.aarp.org/ppi/info-2017/prescription-drug-abuse-among-older-adults.html

 

July 31, 2017

CAAR – Medical Expenditure Panel Survey Data Release – July 31, 2017

Filed under: Data Files — Tags: — admin @ 4:37 pm

The US Agency for Healthcare Research and Quality has released a new MEPS data file (July 2017, data in .zip or self decompressing [.exe] ASCII text and SAS Transport format, with documentation in HTML and .pdf format, and SAS and SPSS programming statements in ASCII format).

MEPS HC-178A: 2015 Prescribed Medicines File

meps.ahrq.gov/mepsweb/data_stats/download_data_files_detail.jsp?cboPufNumber=HC-178A

January 19, 2017

CAAR – Institute for Research on Public Policy [Montreal, Quebec – Canada] Report – January 19, 2017

Filed under: Reports and Articles — Tags: — admin @ 5:01 pm

Improving Prescription Drug Safety for Canadian Seniors,” by Nicole F. Bernier (No. 61, January 2017, .pdf format, 19p.).

irpp.org/research-studies/study-no61/

December 15, 2016

CAAR – AARP Public Policy Institute Report – December 15, 2016

Filed under: Reports and Articles — Tags: — admin @ 5:04 pm

Rx Price Watch Report: Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans: 2006 to 2015,” by Leigh Purvis and Dr. Stephen Schondelmeyer (December 2016, .pdf format, 30p.).

www.aarp.org/ppi/info-2016/trends-in-retail-prices-of-drugs.html

September 12, 2016

CAAR – US Government Accountability Office Report – September 12, 2016

Filed under: Reports and Articles — Tags: , — admin @ 5:12 pm

Generic Drugs Under Medicare: Part D Generic Drug Prices Declined Overall, but Some Had Extraordinary Price Increases,” (GAO-16-706, August 2016, .pdf format, 52p.).

www.gao.gov/products/GAO-16-706

September 7, 2016

CAAR – US Department of Health and Human Services, Office of Inspector General Report – September 7, 2016

Filed under: Reports and Articles — Tags: , — admin @ 4:40 pm

CMS Should Address Medicare’s Flawed Payment System for DME Infusion Drugs,” (OEI-12-16-00340, September 2016, .pdf format, 11p.).

oig.hhs.gov/oei/reports/oei-12-16-00340.asp

July 12, 2016

CAAR – Australian Institute of Health and Welfare Report – July 12, 2016

Filed under: Reports and Articles — Tags: , — admin @ 5:06 pm

Use of medicines by older people with type 2 diabetes,” (July 2016, .pdf format, 120p.).

www.aihw.gov.au/publication-detail/?id=60129555607

May 16, 2016

CAAR – Public Library of Science (PLoS) Articles – May 16, 2016

A. “Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs,” by Roy H. Perlis and Clifford S. Perlis (PLoS ONE 11(5): e0155474. doi:10.1371/journal.pone.0155474, XML, HTML, and .pdf format, 12p.).

journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0155474

B. “The Incidence and Recurrence of Getting Lost in Community-Dwelling People with Alzheimer’s Disease: A Two and a Half-Year,” by Ming-Chyi Pai and Chih-Chien Lee (PLoS ONE 11(5): e0155480. doi:10.1371/journal.pone.0155480, XML, HTML, and .pdf format, 15p.).

journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0155480

April 28, 2016

CAAR – US Senate Special Committee on Aging Hearing Testimony – April 28, 2016

Filed under: Legislation Information Updates — Tags: , — admin @ 4:40 pm

“‘Valeant Pharmaceuticals’ Business Model: the Repercussions for Patients and the Health Care System,” a hearing held April 27, 2016 (witness statement available in .pdf format, video of the full hearing available at the site, running time 3 hours 1 minute). Note: Hearing begins at the 9:54 mark and ends at the 3:10:19 mark

www.aging.senate.gov/hearings/valeant-pharmaceuticals-business-model-the-repercussions-for-patients-and-the-health-care-system

March 17, 2016

CAAR – US Senate Special Committee on Aging Hearing Testimony – March 17, 2016

Filed under: Legislation Information Updates — Tags: , — admin @ 4:54 pm

Sudden Price Spikes in Decades-Old Rx Drugs: Inside the Monopoly Business Model,” a hearing held March 17, 2016 (witness statements available in .pdf format, video of the full hearing available at the site, running time 3 hours 14 minutes). Note: Hearing begins at the 18:03 mark and ends at the 3:32:05 mark.

www.aging.senate.gov/hearings/senate-special-committee-on-aging-to-hold-the-second-hearing-in-a-series-on-sudden-price-spikes-in-decades-old-rx-drugs

December 17, 2015

CAAR – US Department of Health and Human Services, Office of Inspector General Report – December 17, 2015

Filed under: Reports and Articles — Tags: — admin @ 5:01 pm

Average Manufacturer Prices Increased Faster Than Inflation for Many Generic Drugs,” (A-06-15-00030, December 2015, .pdf format, 7p.).

oig.hhs.gov/oas/reports/region6/61500030.asp

December 9, 2015

CAAR – US Senate Special Committee on Aging Hearing Testimony – December 9, 2015

Filed under: Legislation Information Updates — Tags: — admin @ 4:58 pm

Sudden Price Spikes in Off-Patent Drugs: Perspectives from the Front Lines,” a hearing held December 9, 2015 (witness statements in .pdf format, video of the full hearing available at the site, running time 1 hour 59 minutes). Note: Hearing begins at the 14:35 mark.

www.aging.senate.gov/hearings/sudden-price-spikes-in-off-patent-drugs_perspectives-from-the-front-lines

November 20, 2015

CAAR – AARP Public Policy Institute Report – November 20, 2015

Filed under: Reports and Articles — Tags: — admin @ 4:57 pm

Rx Price Watch Report: Trends in Retail Prices of Specialty Drugs,” by Leigh Purvis and Dr. Stephen Schondelmeyer (November 2015, .pdf format, 29p.).

www.aarp.org/ppi/info-2015/trends-in-retail-prices-of-specialty-drugs.html

Older Posts »

Powered by WordPress